François Morvan received his PhD in organic chemistry (1988) at the University of Montpellier (France) under the supervision of Dr Rayner and Prof. Imbach on the synthesis of α-DNA. In 1989, he was hired at the Inserm on modified oligonucleotides for antisense applications. From 1992 to 1993, he worked at Ionis Pharmaceuticals (formerly ISIS Pharmaceuticals, CA, USA), as a senior visiting scientist. He returned to the University of Montpellier where he is currently INSERM Senior Scientist since 2006. In the ChemBioNAC team of the Max Mousseron Institute of Biomolecules, his research focuses on modified oligonucleotides and their conjugates for diagnostic and therapeutic applications, design of neoglycocluster oligonucleotide conjugates and original G-quadruplex analogs. Currently, he develops DNA-inspired aromatic foldamers.